Effects of antiretroviral therapy in patients with Charcot-Marie-Tooth disease type 1A [5]

Journal of Neurology

Volumn 249, Issue 7, 2002, Pages 940-941

  Fernandez Torre J L ^a   Garcia Alcalde M ^a   Alvarez, V ^a  

^a HOSPITAL DE CABUEÑES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; LIDOCAINE; NERVE GROWTH FACTOR; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE ANALOG; PEPTIDE T; STAVUDINE; TRICYCLIC ANTIDEPRESSANT AGENT; VINCRISTINE; ZALCITABINE; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; DYSESTHESIA; ELECTROPHYSIOLOGY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MALE; MICROSATELLITE MARKER; NEUROLOGIC EXAMINATION; NEUROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; TREATMENT CONTRAINDICATION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CHARCOT-MARIE-TOOTH DISEASE; HIV INFECTIONS; HUMANS; MALE; NERVOUS SYSTEM DISEASES; VIRAL LOAD;

EID: 0036307513     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0719-z     Document Type: Letter

References (7)

1. 2′,3′-dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients
2. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A
3. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome
4. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A
5. Peripheral neuropathy with nucleoside antiretrovirals. Risk factors, incidence and management
6. Nucleoside analogue-associated peripheral neuropathy in human inmunodeficiency virus infection
7. HIV-associated peripheral neuropathy. Epidemiology, pathophysiology and treatment